Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: GWAS for Genetic Determinants of Bone Fragility      
citations:
8461578
9844108
10999795
14730478
15205721
16598376
16813533
description:
Osteoporotic fractures are largely due to an increased propensity to fall with aging and a reduction in bone strength. Although skeletal architecture contributes to fracture risk, bone mineral density (BMD) is the most important determinant of bone strength and fracture risk. Between 60 and 80% of the variance of BMD of adult Caucasian women is due to heritable factors. Final BMD is a function of peak bone mass attained during young adulthood and the subsequent rate of bone loss, which occurs as a result of both post-menopausal estrogen loss and aging. The evidence for a genetic contribution to rate of loss in BMD is substantially weaker than that for peak BMD. Therefore, we have focused our sample collection on the recruitment of premenopausal women, in whom we have sought to identify the genes influencing peak BMD at the spine and hip, the two major skeletal sites of osteoporotic fracture. The primary goal of this study is to identify genes that affect peak BMD in premenopausal women. Identification of these genes may: 1) lead to molecular tests that predict risk of osteoporosis and allow institution of early preventive measures; 2) provide insight into basic bone cell biology and other factors that affect peak BMD; and 3) provide molecular targets for therapeutic agents to increase BMD.
Identifier:
phs000138.v2.p1
accesstypes:
download
enclave
landingpage: http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000138.v2.p1
authentication: simpleLogin
none
authorization:
none
duaIndividual
name:
Osteoporosis
Osteoporosis, Postmenopausal
Bone Density
affiliations:
Indiana University School of Medicine, Indianapolis, IN, USA
name:
Michael J. Econs, MD
roles:
Principal Investigator
affiliations:
National Institute of Aging, National Institutes of Health, Bethesda, MD, USA
name:
Winifred Rossi
roles:
Investigator
affiliations:
National Institutes of Health, Bethesda, MD, USA
name:
P01# AG018397
roles:
Funding Source
affiliations:
National Institutes of Health, Bethesda, MD, USA
name:
HHSN268200782096C. "NIH contract High throughput genotyping for studying the genetic contributions to human disease"
roles:
Funding Source for Genotyping
performedBy:
TitleNameInstitute Principal InvestigatorMichael J. Econs, MDIndiana University School of Medicine, Indianapolis, IN, USA InvestigatorWinifred RossiNational Institute of Aging, National Institutes of Health, Bethesda, MD, USA Funding SourceP01# AG018397National Institutes of Health, Bethesda, MD, USA Funding Source for GenotypingHHSN268200782096C. "NIH contract High throughput genotyping for studying the genetic contributions to human disease"National Institutes of Health, Bethesda, MD, USA
downloadURL: https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&view_pdf&stacc=phs000138.v2.p1
Identifier:
phs000138.v2.p1_policy
name:
Data Use Certificate
Identifier:
0
name:
Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects.
Identifier:
1
name:
General Research Use
schedulesActivity:
Genetic studies of bone density at Indiana have been ongoing since 1988, beginning with studies in twin pairs. This has expanded over time to include sibling pair linkage and association studies of both men and women, and both European-American and African-American subjects. Peak bone mineral density as measured premenopausally in women and before age 60 in men is the primary quantitative phenotype of interest, specifically at the femoral neck and lumbar spine.
alternateIdentifiers:
yes
selectionCriteria:

The sample consists of European-American premenopausal sister pairs from Indiana, at least 20 years of age. The subjects were recruited without regard to bone density or other clinical phenotype, and therefore represent an ideal cohort in which to study genetic influences on normal variation in peak BMD. The exclusion criteria were limited to irregular menses or a history of pregnancy or lactation within three months prior to enrollment, a history of chronic disease, current medications known to affect bone mass or metabolism, or inability to have BMD measured due to obesity.

types:
Quantitative Cross-Sectional
dateReleased:
04-29-2010
version:
phs000138.v2.p1
dateModified:
05-24-2010
abbreviation:
JAAMH
name:
Joint Addiction, Aging, and Mental Health DAC
ID:
0
name:
dbGaP

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.